Prevalence of skin manifestations in patients with β- thalassemia and its association with serum hemoglobin and serum ferritin in Diyala province
Keywords:
Prevalence, skin manifestations, β-thalassemia, serum hemoglobin, serum ferritinAbstract
Introduction: β-Thalassemia is a blood disease that associated with decrease in hemoglobin (Hb) production. Hemoglobin is the iron-containing protein located inside red blood cells (RBC), their function is transport oxygen to all cells in the body. The aim of study is to identify the prevalence of skin manifestations in patients with β-thalassemia and its association with serum hemoglobin and serum ferritin. Method: cross sectional design for 367 patients with thalassemia, the data collected from Hematological word in Baqubah teaching hospital. The period of study from April 2021 to February 2022. Study population: Diagnosed cases of Beta thalassemia major and intermedia patients between 2 to 38 years’ age already diagnosed Hb electrophoresis by hemoglobinelectrophoresis attended to Hematological word in Baqubah teaching hospital. Results: study of 367 patients with thalassemia, (60.2%) of patients at age group 1-3 years, (58%) of patients are males and (42%) of them are females. (71.9%) of patents have received regular blood transfusion. (80.9%) of patients have paler, (71.7%) of patients have xerosis, (50.4%) of them have jaundice, (76%) of patients have bronze skin, (55%) of patient’s have hyperpigmentation, (40.1%) of patients have pruritus. Conclusion: most thalassemia patients are males at age group 1-3 years they received regular blood transfusion. The most prevalence skin manifestations of thalassemia are pallor, xerosis, bronze skin, yellowish discoloration of skin (jaundice), also most patients had pruritus and hyperpigmentation.
Downloads
References
Bajwa H, & Basit H (2022) Thalassemia. In StatPearls.
Treasure Island (FL): StatPearls Publishing. URL:
http://www.ncbi.nlm.nih.gov/books/nbk545151/
Canatan D (2014) Thalassemias and hemoglobinopathies
in Turkey. Hemoglobin 38 (5): 305-307. DOI:
https://doi.org/10.3109/03630269.2014.938163
Croom D, Barlow T, & Landers JT (2019) Pruritic rash on
chest and back. J Fam Pract 68 (2): 113-116. URL:
https://pubmed.ncbi.nlm.nih.gov/30870537/
De Sanctis V, Soliman AT, Canatan D, Yassin MA,
Daar S et al. (2019) Thyroid Disorders in
Homozygous β-Thalassemia: Current Knowledge,
Emerging Issues and Open Problems. Mediterr J
Hematol Infect Dis 11 (1): e2019029. DOI:
https://doi.org/10.4084/mjhid.2019.029
Dogramaci AC, Savas N, Ozer B, & Duran N (2009)
Skin diseases in patients with beta-thalassemia
major. Int J Dermatol 48 (10): 1057-1061. DOI:
https://doi.org/10.1111/j.1365-4632.2009.04176.x
El-Dash H, & Adel S (2018) Cutaneous
manifestations in Egyptian children with betathalassemia major: Relationship with serum
ferritin, thyroid profile, and treatment
modalities. Pediatr Dermatol 35 (5): 639-643.
DOI: https://doi.org/10.1111/pde.13570
Fahmey SS, Taha G, El-Refaey A, & Adly S (2018) Skin
Disorders in Egyptian Children with β-Thalassemia
Major. J Trop Pediatr 64 (2): 104-109. DOI:
https://doi.org/10.1093/tropej/fmx035
Gupta MA, & Gupta AK (2004) Stressful major life
events are associated with a higher frequency
of cutaneous sensory symptoms: an empirical
study of non-clinical subjects. J Eur Acad
Dermatol Venereol 18 (5): 560-565. DOI:
https://doi.org/10.1111/j.1468-3083.2004.00931.x
López-Martínez R, Manzano-Gayosso P, HernándezHernández F, Bazán-Mora E, & Méndez-Tovar
LJ (2010) Dynamics of dermatophytosis
frequency in Mexico: an analysis of 2084 cases.
Med Mycol 48 (3): 476-479. DOI:
https://doi.org/10.3109/13693780903219006
Miazek N, Michalek I, Pawlowska-Kisiel M,
Olszewska M, & Rudnicka L (2015) Pityriasis
Alba--Common Disease, Enigmatic Entity: Upto-Date Review of the Literature. Pediatr
Dermatol 32 (6): 786-791. DOI:
https://doi.org/10.1111/pde.12683
Mishra AK, & Tiwari A (2013) Iron overload in Beta
thalassaemia major and intermedia patients.
Maedica (Bucur) 8 (4): 328-332. URL:
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc
/
Pande SY, & Kharkar V (2014) Clinical profile of
cutaneous manifestations with and without
hematologic disease: A comparative study. Indian
Dermatol Online J 5 (2): 138-143. DOI:
https://doi.org/10.4103/2229-5178.131081
Roy K, Das SK, Dutta A, & Mandal RK (2018)
Dermatological manifestations in beta
thalassemia major patients between 2 to 12
years and their relation with serum
ferritine level. Journal of the Pediatrics
Association of India 7 (3): 149-157. URL:
https://www.jpai.in/temp/JPediatrAssocIndia73
-4708302_130443.pdf
Sayani FA, & Kwiatkowski JL (2015)
Increasing prevalence of thalassemia in
America: Implications for primary care.
Ann Med 47 (7): 592-604. DOI:
https://doi.org/10.3109/07853890.2015.1091942
Traeger-Synodinos J, Vrettou C, & Kanavakis E
(2019) Rapid Detection of Fetal Mendelian
Disorders: Thalassemia and Sickle Cell
Syndromes. Methods Mol Biol 1885: 207-219.
DOI: https://doi.org/10.1007/978-1-4939-8889-1_14
Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller
AS et al. (2008) Fitzpatrick's dermatology in
general medicine (7th ed.). McGraw-Hill. URL:
https://www.scholars.northwestern.edu/en/publ
ications/fitzpatricks-dermatology-in-generalmedicine-7th-edition-2
Yassin MA, Soliman AT, De Sanctis V, Yassin
KS, & Abdulla MA (2019) Final Height and
Endocrine Complications in Patients with β-
Thalassemia Intermedia: Our Experience in
Non-Transfused Versus Infrequently
Transfused Patients and Correlations with
Liver Iron Content. Mediterr J Hematol
Infect Dis 11 (1): e2019026. DOI:
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
